Hims & Hers Health, Inc. (HIMS) shares fell 8.06 percent to $23.03, down $2.02 on Monday, after the telehealth company announced plans to offer $300 million of convertible senior notes due 2032 in a private placement to qualified institutional buyers.
The stock is currently trading at $23.03, compared with a previous close of $25.05 on the New York Stock Exchange. It opened at $23.98 and traded between $22.73 and $23.98 during the session, with volume reaching 10.66 million shares, below the average daily volume of 36.45 million shares.
The company also expects to grant initial purchasers an option to buy up to an additional $45 million of notes. Hims & Hers said it plans to use the proceeds to maintain financial flexibility, support its international expansion strategy, fund the proposed acquisition of Eucalyptus, invest in technology and fulfillment infrastructure, and expand artificial intelligence capabilities.
Hims & Hers shares have traded between $13.74 and $70.43 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.